Be transparent about your medical history and any concerns you may have
Abbreviations: V: vehicle, CS: CagriSema, and WM: Weight matched
Who Should Consider GLP-1 Therapy FDA indications for weight loss require: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or similar These thresholds set eligibility, but they don't answer the more important question: who benefits most
Benefits and Expectations with Semaglutide Treatment Treatment begins with the lowest effective dose of semaglutide, adjusted over time to optimally support weight loss
This study included patients with and without a history of T2DM
Maternal multiple micronutrient supplementation in rural Pakistan increased some milk micronutrient concentrations, but not infant growth, at three-months postpartum: a randomized controlled trial substudy